During the past decade, Oivauni Oy - Tampere conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oivauni Oy - Tampere" are "Insomnia Disorder" (2 trials). Many other conditions were trialed in "Oivauni Oy - Tampere" in a lesser frequency.

Most popular intervention types in "Oivauni Oy - Tampere" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Daridorexant" (1 trials), "Daridorexant 10 mg" (1 trials), "Daridorexant 25 mg" (1 trials) and "Daridorexant 50 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oivauni Oy - Tampere" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oivauni Oy - Tampere". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Oivauni Oy - Tampere, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oivauni Oy - Tampere, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".